Novo attempts to parry Sanders' GLP-1 pricing complaints by calling out pharma middlemen

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 29, 2024 at 09:42: PM
via Novo Nordisk is standing its ground after the Senate’s Health, Education, Labor and Pensions (HELP) committee recently accused the drugmaker of threatening to bankrupt the U.S. healthcare system with its pricey GLP-1 medicines.

article source
 

<



Similar threads

cafead
Novo obesity prospect linked to ‘mild to moderate neuropsychiatric side effects’ in phase 2
Replies
0
Views
21
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
EU regulator backs use of Novo&#039;s Wegovy for obesity-related heart condition
Replies
0
Views
2
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Novo Nordisk bets $600M biobucks on NanoVation&#039;s ability to take genetic medicines beyond the liver
Replies
0
Views
32
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Obesity pill race heats up as Novo, Roche and Terns share data
Replies
0
Views
44
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Novo Nordisk hails ‘remarkable’ weight loss result for dual-acting oral drug in early trial
Replies
0
Views
29
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote